Pasanting, Jene Rose .
HRN: 28-18-35 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2025
CEFUROXIME 500MG (TAB)
11/28/2025
12/05/2025
ORAL
500 Mg
Bid
S/p Nsvd With Rmle
Checking Initial Appropriateness